Literature DB >> 17388950

Neuropathologic contributions to understanding AIDS and the central nervous system.

Francesco Scaravilli1, Céline Bazille, Françoise Gray.   

Abstract

This historical review describes the evolution of the pathogenetic concepts associated with infection by the Human Immunodeficiency Virus (HIV), with emphasis on the pathology of the nervous system. Although the first descriptions of damage to the nervous system in the acquired immunodeficiency syndrome (AIDS) only appeared in 1982, the dramatic diffusion of the epidemic worldwide and the invariably rapidly fatal outcome of the disease, before the introduction of efficient treatment, generated from the beginning an enormous amount of research with rethinking on a number of pathogenetic concepts. Less than 25 years after the first autopsy series of AIDS patients were published and the virus responsible for AIDS was identified, satisfactory definition and classification of a number of neuropathological complications of HIV infection have been established, leading to accurate clinical radiological and biological diagnosis of the main neurological complications of the disease, which remain a major cause of disability and death in AIDS patients. Clinical and experimental studies have provided essential insight into the pathogenesis of CNS lesions and natural history of the disease. The relatively recent introduction of highly active antiretroviral therapy (HAART) in 1995-1996 has dramatically improved the course and prognosis of HIV disease. However, there remain a number of unsolved pathogenetic issues, the most puzzling of which remains the precise mechanism of neuronal damage underlying the specific HIV-related cognitive disorders (HIV dementia). In addition, although HAART has changed the course of neurological complications of HIV infection, new issues have emerged such as the lack of improvement or even paradoxical deterioration of the neurological status in treated patients. Interpretation of these latter data remains largely speculative partly because of the small number of neuropathological studies related to the beneficial consequence of this treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17388950     DOI: 10.1111/j.1750-3639.2007.00047.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  12 in total

1.  Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS.

Authors:  Efe Sezgin; Sher L Hendrickson; Douglas A Jabs; Mark L Van Natta; Richard A Lewis; Jennifer L Troyer; Stephen J O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

2.  CD8 T lymphocytes encephalitis mimicking brain tumor in HIV-1 infection.

Authors:  Antoine Moulignier; Julien Savatovsky; Marc Polivka; David Boutboul; Raphael Depaz; François-Xavier Lescure
Journal:  J Neurovirol       Date:  2013-11-26       Impact factor: 2.643

3.  Structural gray and white matter changes in patients with HIV.

Authors:  Michael Küper; K Rabe; S Esser; E R Gizewski; I W Husstedt; M Maschke; M Obermann
Journal:  J Neurol       Date:  2011-01-05       Impact factor: 4.849

4.  White matter fiber bundle lengths are shorter in cART naive HIV: an analysis of quantitative diffusion tractography in South Africa.

Authors:  Jodi M Heaps-Woodruff; John Joska; Ryan Cabeen; Laurie M Baker; Lauren E Salminen; Jacqueline Hoare; David H Laidlaw; Rachel Wamser-Nanney; Chun-Zi Peng; Susan Engelbrecht; Soraya Seedat; Dan J Stein; Robert H Paul
Journal:  Brain Imaging Behav       Date:  2018-10       Impact factor: 3.978

Review 5.  Differential diagnosis of white matter lesions: Nonvascular causes-Part II.

Authors:  S Weidauer; M Nichtweiss; E Hattingen
Journal:  Clin Neuroradiol       Date:  2014-02-12       Impact factor: 3.649

Review 6.  Magnetic Resonance Imaging and Clinical Features in Acute and Subacute Myelopathies.

Authors:  Stefan Weidauer; Marlies Wagner; Michael Nichtweiß
Journal:  Clin Neuroradiol       Date:  2017-06-30       Impact factor: 3.156

7.  Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders.

Authors:  Alejandra Borjabad; Susan Morgello; Wei Chao; Seon-Young Kim; Andrew I Brooks; Jacinta Murray; Mary Jane Potash; David J Volsky
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

8.  Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice.

Authors:  Boe-Hyun Kim; Jennifer Kelschenbach; Alejandra Borjabad; Eran Hadas; Hongxia He; Mary Jane Potash; Michael T Nedelcovych; Rana Rais; Norman J Haughey; Justin C McArthur; Barbara S Slusher; David J Volsky
Journal:  AIDS       Date:  2019-05-01       Impact factor: 4.632

9.  Efficient Expression of HIV in Immunocompetent Mouse Brain Reveals a Novel Nonneurotoxic Viral Function in Hippocampal Synaptodendritic Injury and Memory Impairment.

Authors:  Jennifer Kelschenbach; Hongxia He; Boe-Hyun Kim; Alejandra Borjabad; Chao-Jiang Gu; Wei Chao; Meilan Do; Leroy R Sharer; Hong Zhang; Ottavio Arancio; Mary Jane Potash; David J Volsky
Journal:  mBio       Date:  2019-07-02       Impact factor: 7.867

10.  The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in Thai patients.

Authors:  Reto Nüesch; Angèle Gayet-Ageron; Ploenchan Chetchotisakd; Wisit Prasithsirikul; Sasisopin Kiertiburanakul; Warangkana Munsakul; Phitsanu Raksakulkarn; Somboon Tansuphasawasdikul; Sineenart Chautrakarn; Kiat Ruxrungtham; Bernard Hirschel; Jintanat Anaworanich
Journal:  Open AIDS J       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.